Neurontin, Paxil Suits Demonstrate Complications Of State Prosecutions
Executive Summary
Increased intervention by states in federal prosecutions of pharmaceutical companies is likely to make global settlement negotiations much more complicated, Boston Assistant U.S. Attorney Michael Loucks said June 22 at an Institute for International Research conference in Boston
You may also be interested in...
State AGs To Discuss Drug Pricing, Marketing At January Summit
The National Association of Attorneys General will discuss pharmaceutical pricing and marketing at a summit in January
State AGs To Discuss Drug Pricing, Marketing At January Summit
The National Association of Attorneys General will discuss pharmaceutical pricing and marketing at a summit in January
FDA Should Oversee Clinical Trial Disclosure, New York AG Spitzer Says
FDA should take the lead in defining rules for clinical trial reporting to eliminate the issue of "publication bias," New York Attorney General Eliot Spitzer said during a recent appearance at the Chautauqua Institution in New York